General Updates

Ind-Swift Laboratories Limited A, Registered Office \ SCO 850, Shivalik Enclave, . NAC Manimajra, Sector 13, . Chandigarh - 160101 INDIA !':ad_.,s“l'[hd 52 info@indswiftlabs.com e Wrkd One Hesth one nd-Swift @ 01722730503, 2730920, 5061851-53 CIN No. L24232CH1995PLC015553 Ref: ISLL:CH:2026 Date: 21% September, 2026 Corporate Relationship Department Listing Compliance Department, BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5% Floor 25t Floor, Dalal Street, Plot No. C/2, G-Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (E), Mumbai 400 051 ISIN: INE915B01019 BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB Subject: Disclosures under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 Dear Sir/Ma’am, Please find enclosed herewith disclosures received under Regulation 29(2) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 21° September, 2026 from Essix Biosciences Limited. You are requested to take the same on your record. Thanking you, For IND-SWIFT LABORATORIE; PARDEEP VERMA VP-CORPORATE AFFAIRS & COMPANY SECRETARY Manufacturing Facilities: Unit I: NH-21, Village Jawaharpur, Tehsil Derabassi, District SAS Nagar (Mohali), Punjab - 140507 Unit II: Phase 1, SIDCO Industrial Growth Centre, Samba, Jammu & Kashmir- 184121 Followus: QODOO Q@ 0172-2730503, 2730920, 5061851-53 53 info@indswiftlabs.com € www.indswiftgroup.com Forverifying authenticity of this letter, please reach us by sending copy of same on hr ho@indswiftlabs.com Essix Biosciences Limited Regd. OFf. : SCO 850, Shivalik Enclave, NAC Manimajra, Chandigarh - 160101 (INDIA) Phone : +91-172-2730503, 2730920, Fax : +91-172-2730504, 2736294 Place of Business: Village Bhabat, Zirakpur Ambala Highway, Zirakpur, Mohali- Punjab (India) Ph. +91-9317812731, CIN NO. U74999CH1993PLC033428 Date: September 21, 2026 To, To, The Listing Compliance Department The Listing Compliance Department, National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, P. J. Tower, Dalal Street Bandra (East), Mumbai - 400051 Mumbai — 400001 Symbol: INDSWFTLAB Scrip Code: 532305 Subject : Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Dear Sir/Madam, With reference to the captioned subject, I, Himanshu Jain, Director on behalf of Essix Biosciences Limited ("Acquirer"), belonging to the Promoter and Promoter Group of Ind-Swift Laboratories Limited ("'Target Company"), along with Gopal Munjal, Himanshu Jain, N.R. Munjal, Rishav Mehta, S.R. Mehta, V.R. Mehta, Annie Mehta, Bhanavi Mehta, Divya Munjal, Ishav Mehta, Meenakshi Mehta, Neeta Munjal, Nidhi Munjal, Ravi Mehta, Sahil Munjal, Sunita Jain, Saurabh Munjal, Deepti Munjal & Daksh Mehta (hereinafter collectively referred to as "PACs") hereby inform your good office that the Acquirer has acquired 70,00,000 (Seventy Lakh) Fully Convertible Warrants (“Warrants™), for cash, to be convertible into an equivalent number of Equity Shares off ace value of Rs. 10/- each oft he Target Company, on Thursday, September 17, 2026, on a preferential basis. In this regard, please find enclosed the disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, by Essix Biosciences Limited, on behalf oft he whole Promoter & Promoter group oft he Company. You are requested to take the same on records. Thanking You, Yours Sincerely, For Essix Biosci Date: September 21, 2026 Place: Chandigarh CcC: The Board of Directors Ind-Swift Laboratories Limited SCO0:850, Shivalik Enclave, NAC, Manimajra, Chandigarh, 160101, India Essix Biosciences Limited Regd. OFF. : SCO 850, Shivalik Enclave, NAC Manimajra, Chandigarh - 160101 (INDIA) Phone : +91-172-2730503, 2730920, Fax : +91-172-2730504, 2 Punjab (Indic) Place of Business: Village Bhabat, Zirakpur Ambala Highway, Zirakpur, Mohali- Ph. +91-9317812731, CIN NO. U74999CH1993PLC033428 Disclosures under Reg. 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 Name of the Target Company (TC) Ind- Swift Laboratories Limited Names of the Acquirer and Person Acting in Concert Essix Biosciences Limited (PAC) with the Acquirer (“Acquirer”) 1. Gopal Munjal; 2. Himanshu Jain; 3. N.R Munjal; 4. Rishav Mehta; 5. S.R.Mehta; 6. V.R. Mehta; 7. Annie Mehta; 8. Bhanavi Mehta; 9. Divya Munjal; 10. TIshav Mehta; 11. Meenakshi Mehta; 12. Neeta Munjal; 13. Nidhi Munjal; 14. Ravi Mehta; 15. Sahil Munjal; 16. Sunita Jain; 17. Saurabh Munjal; 18. Deepti Munjal; & 19. Daksh Mehta (hereinafter collectively referred to as “PACs”) ‘Whether the acquirers belong to Promoter/ Promoter Yes group Name(s) of the Stock Exchange(s) where the shares of TC 1. National Stock Exchange of India Limited are Listed (“NSE”) and 2. BSE Limited (“BSE”) Details of the acquisition as follows Number of [ % w.r.t. total % w.r.t. total Shares share/voting diluted share/ capital voting capital wherever of the TC applicable Before the acquisition under consideration, holding of: a) Shares carrying voting rights = Essix Biosciences Limited 3,28,82,521 37.92 37.92 * PACs 44,51,757 5.13 5.13 b) Shares in the nature of encumbrance 0 0.00 0.00 ¢) Voting rights (VR) otherwise than by shares 0 0.00 0.00 d) Warrants /convertible securities/any other instrument that 0 0.00 0.00 entitles the acquirer to receive shares carrying voting rights in the TC acquired/sold Total (a+b+c+d) 3,73,34,278 43.06 43.06 Details of acquisition: [ 0.00 0.00 a) Shares carrying voting rights acquired/seld Essix Biosciences Limited Regd. Off. : SCO 850, Shivalik Enclave, NAC Manimaijra, Chandigarh - 160101 (INDIA) Phone : +91-172-2730503, 2730920, Fax : +91-172-2730504, 2736294 Place of Business: Village Bhabat, Zirakpur Ambala Highway, Zirakpur, Mohali- Punjab (Indic) Ph. +91-9317812731, CIN NO. U74999CH1993PLC033428 b) Shares in the nature of encumbrance 0 0.00 0.00 ¢) Voting rights (VR) otherwise than by shares 0 0.00 0.00 d) Warrants /convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC acquired/seld = _Essix Biosciences Limited 70,00,000 - 745 Total (a+b+c+d) 70,00,000 0.00 745 After the acquisition/sale, holding of: a) Shares carrying voting rights = Essix Biosciences Limited 3,28,82,521 37.81° 35.00 = PACs 44,51,757 5.12° 4.74 b) Shares in the nature of encumbrance 0 0.00 0.00 ¢) Voting rights (VR) otherwise than by shares 0 0.00 0.00 d) Warrants /convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC acquiredisetd = Essix Biosciences Limited 70,00,000 - 745 Total (a+b+ct+d) 4,43,34,278 42.93 47.18 Mode of acquisition /-sale Allotment of Fully Convertible Warrants through Preferential Issue by the Target Company. Date of receipt of intimation of allotment of shares September 17, 2026 ("Date of Allotment") Equity share capi/t taotlal voting capital of the TC before | Rs. 86,71,15,580/- comprising of 8,67,11,558 the said acquisition Equity Shares of Rs. 10/- each Equity share capital/ total voting capital of the TC after | Rs. 86,96,15,580/- comprising of 8,69,61,558 the said acquisition Equity Shares of Rs. 10/- each Total diluted share/voting capital of the TC after the said | Rs. 93,96,15,580/- comprising of 9,39,61,558 acquisition Equity Shares of Rs. 10/- each * These percentages have been calculated on the basis of the post-preferential share capital of 8,69,61,558 Equity Shares of the Company, including 2,50,000 Equity Shares allotted pursuant to the exercise of ESOPs. For Essix Bioscigntes Date: September 21, 2026 Place: Chandigarh